Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Clinigen Group has signed an exclusive agreement with Lukare Medical to manage the supply and distribution of Elliotts B Solution.
read more
US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, announced today it has been selected by Rigel Pharmaceuticals to dispense TAVALISSE™ (fostamatinib disodium hexahydrate) Tablets.TAVALISSE™ was approved by the U.S. Food and ...
read more
Micromeritics Instrument Corporation, a leading global manufacturer of premium products for advanced material characterisation, today announced the acquisition of Freeman Technology. Freeman Technology specialises in providing instruments for the ...
read more
Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial ...
read more
Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization...
read more
A new £56 million UK innovation centre, which will revolutionise how medicines are manufactured, is to be located in Renfrewshire.
read more
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces that it has been selected by Pierre Fabre ...
read more
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the ...
read more
According to a new report published by Allied Market Research, titled, "Antibody Drug Conjugates Market by Drugs, Mechanism of Action and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global antibody drug conjugates ...
read more
AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million investment round financed by Epidarex Capital and CRT Pioneer Fund ('CPF').
read more
Based on its recent analysis of the North American clinical trial IT solutions market, Frost & Sullivan recognizes Oracle Health Sciences with the 2018 North American Enabling Technology Leadership Award for its new eClinical platform, Clinical One™ ...
read more
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to ...
read more
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 myeloid checkpoint mechanism, today announced the change of the Company’s name to ALX Oncology. The new name and logo will differentiate ALX Oncology ...
read more
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center.
read more
India-Based APAC Biotech and US-Based Diakonos Research sign a first-of-its-kind technology transfer and licensing agreement to bring new immunotherapy technology to India as an advancement of immuno-oncology therapeutics for solid tumors.
read more